Cite
Tanton C, Mesher D, Beddows S, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017;3:36-41doi: 10.1016/j.pvr.2017.01.001.
Tanton, C., Mesher, D., Beddows, S., Soldan, K., Clifton, S., Panwar, K., Field, N., Mercer, C. H., Johnson, A. M., & Sonnenberg, P. (2017). Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus research (Amsterdam, Netherlands), 336-41. https://doi.org/10.1016/j.pvr.2017.01.001
Tanton, Clare, et al. "Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types." Papillomavirus research (Amsterdam, Netherlands) vol. 3 (2017): 36-41. doi: https://doi.org/10.1016/j.pvr.2017.01.001
Tanton C, Mesher D, Beddows S, Soldan K, Clifton S, Panwar K, Field N, Mercer CH, Johnson AM, Sonnenberg P. Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41. doi: 10.1016/j.pvr.2017.01.001. PMID: 28626810; PMCID: PMC5462921.
Copy
Download .nbib